13 July 2018
("CAP-XX" or "the Company")
Exercise of share options
CAP-XX Limited, a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems, announces that an ex-employee has today exercised 937,500 options to subscribe for new ordinary shares in the Company.
Pursuant to this exercise of options, CAP-XX will make an application for a total of 937,500 new ordinary shares in the Company (the "New Shares") to be admitted to trading on AIM. Trading in the New Shares is expected be become effective on 23 July 2018.
Following the issue of the New Shares, the Company will have a total of 300,823,587 ordinary shares in issue. Therefore, the total number of ordinary shares with voting rights will be 300,823,587 which may be used by shareholders in the Company as the denominator for calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.
For further information contact:
Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139
Kreab (Financial PR)
Robert Speed +44 (0) 20 7074 1800
Allenby Capital (Nominated Adviser and Broker)
David Hart / Alex Brearley (Corporate Finance) +44 (0) 20 3328 5656
More information is available at www.cap-xx.com
Notes to Editors:
CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and large supercapacitor based modules used in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact firstname.lastname@example.org or visit www.rns.com.